No takes yet. Share an insight, caveat, or question.
Randomized trial develops a prognostic model for survival prediction in patients with stage II-IV epithelial ovarian cancer, highlighting its clinical utility.
Ying et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: